ArticleTranslational cancer research2021
Intralobar pulmonary sequestration with aspergillus infection and elevated serum CA19-9 and CA242: a case report.
Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- A rare case of pulmonary sequestration with elevated CA19-9 levels.Annals of medicine and surgery (2012) · 2026Article
- Intralobar pulmonary sequestration masquerading as a giant lung abscess in a 16-year-old male: a case report and literature review.Journal of cardiothoracic surgery · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sequestration is a rare congenital dysplasia, and intralobar pulmonary sequestration was caused by aspergillus infection are more uncommon. The significant increase of serum CA19-9 and CA242 often indicates malignant tumors of the pancreas, biliary tract and gastrointestinal tract, but it is different in this case we reported. We present a case of a 36-year-old woman with intralobar pulmonary sequestration with aspergillus infection and elevated serum tumor markers CA19-9 and CA242. The patient had a right lung occupying lesion on the chest CT and sulfur particles are formed in the lesioned bronchial lumen. According to the results of the imaging and pathological, and serum CA19-9 and CA242 increased significantly, it was initially suspected to be a malignant tumor, so the right lobectomy and lymph node dissection were performed. Postoperative pathological examination confirmed intralobar pulmonary sequestration with aspergillus infection. After 22 days of surgery, the level of serum CA19-9 and CA242 were significantly decreased and gradually decreased to normal. This is a rare case of pulmonary sequestration accompanied by aspergillus infection in which serum CA19-9 and CA242 are elevated; it's also the first report that pulmonary sequestration accompanied by aspergillus infection with sulfur particles formation. It is suggested that patients with pulmonary sequestration, especially those complicated with aspergillus infection, may be accompanied by elevated serum tumor markers CA19-9 and CA242, which should not be misdiagnosed as malignant tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.